Table 1.
Main characteristics of all studies included in the meta-analysis
|
rs12203592 |
Case |
|
|
Control |
|
|
|
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First author | Year | Country | Ethnicity | Cancer type | Source of controls | CC | TC | TT | CC | TC | TT | HWE |
| Gathany [24] |
2009 |
USA |
Mixed |
NHL |
PB |
730 |
239 |
19 |
605 |
202 |
18 |
0.814 |
| Wang 1 [40] |
2009 |
USA |
Mixed |
NHL |
PB |
299 |
123 |
13 |
357 |
143 |
15 |
0.882 |
| Wang 2 [40] |
2009 |
USA |
Mixed |
NHL |
PB |
332 |
157 |
29 |
283 |
160 |
19 |
0.541 |
| Kvaskoff [34] |
2011 |
France |
Caucasians |
Melanoma |
HB |
654 |
307 |
48 |
871 |
518 |
79 |
0.862 |
| Han 1 [35] |
2011 |
USA |
Caucasians |
Melanoma |
HB |
123 |
54 |
11 |
450 |
163 |
19 |
0.369 |
| Han 2 [35] |
2011 |
USA |
Caucasians |
Melanoma |
HB |
126 |
68 |
20 |
565 |
232 |
29 |
0.394 |
| Pena-Chilet [32] |
2013 |
Spain |
Caucasians |
Melanoma |
PB |
398 |
121 |
19 |
242 |
101 |
19 |
0.055 |
| Han 3 [35] |
2011 |
USA |
Caucasians |
SCC |
HB |
156 |
80 |
15 |
450 |
163 |
19 |
0.369 |
| Han 4 [35] |
2011 |
USA |
Caucasians |
SCC |
HB |
143 |
110 |
20 |
565 |
232 |
29 |
0.394 |
| Han 5 [35] |
2011 |
USA |
Caucasians |
BCC |
HB |
139 |
54 |
20 |
503 |
191 |
24 |
0.269 |
| Han 6 [35] |
2011 |
USA |
Caucasians |
BCC |
HB |
174 |
81 |
19 |
565 |
232 |
29 |
0.394 |
|
rs872071 |
Case |
Control |
||||||||||
|
First author |
Year |
Country |
Ethnicity |
Cancer type |
Source of controls |
AA |
AG |
GG |
AA |
AG |
GG |
HWE |
| Di Bernardo 1 [27] |
2008 |
UK |
Caucasians |
CLL |
HB |
63 |
248 |
190 |
305 |
720 |
411 |
0.754 |
| Di Bernardo 2 [27] |
2008 |
UK |
Caucasians |
CLL |
PB |
67 |
232 |
201 |
183 |
391 |
202 |
0.816 |
| Lan [36] |
2010 |
USA |
Asians |
CLL |
HB |
21 |
36 |
12 |
602 |
534 |
127 |
0.978 |
| Crowther-Swanepoel [37] |
2010 |
UK |
Caucasians |
CLL |
PB |
74 |
203 |
117 |
129 |
179 |
89 |
0.076 |
| Broderick 1 [39] |
2010 |
UK |
Caucasians |
HL |
PB |
16 |
55 |
36 |
228 |
519 |
278 |
0.629 |
| Broderick 2 [39] |
2010 |
UK |
Caucasians |
HL |
PB |
83 |
198 |
118 |
259 |
562 |
269 |
0.302 |
| Pratt [38] |
2010 |
UK |
Caucasians |
MM |
PB |
82 |
169 |
101 |
183 |
388 |
200 |
0.846 |
| Qiao [33] | 2013 | China | Asians | NHL | HB | 341 | 381 | 64 | 777 | 653 | 112 | 0.112 |
BCC: Basal cell carcinoma; SCC: Squamous cell carcinoma; HL: Hodgkin lymphoma; NHL: Non-Hodgkin lymphoma; MM: Multiple myeloma; CLL: Chronic lymphocytic leukaemia.
PB: population based; HB: hospital based.
HWE: Hardy-Weinberg equilibrium.